Document:

Exhibit 10.24

              THIRD AMENDMENT TO AMENDED AND RESTATED INVENTORY AND
                         RECEIVABLES PURCHASE AGREEMENT

     This Third Amendment to Amended and Restated Inventory and Receivables
Purchase Agreement (the "Third Amendment") is entered into as of September 14,
2006 by and between Intraop Medical Corporation, a Nevada Corporation
("Company") and E.U. Capital Venture, Inc., a Nevada Corporation and E.U.C.
Holding, a Danish corporation (together, "Buyer").

                                    RECITALS

     WHEREAS, Company and Buyer entered into an Amended and Restated Inventory
and Receivables Purchase Agreement dated as of April 10, 2006, as amended on May
24, 2006 and August 14, 2006 (the "Restated Agreement").

     WHEREAS, Company and Buyer desire to amend certain provisions of the
Restated Agreement as set forth below.

                                    AGREEMENT

     NOW, THEREFORE, for good and valuable consideration, and intending to be
legally bound, the parties hereby agree as follows:

1.       Amendment of Section 2.1:

         Section 2.1 of the Restated Agreement is amended in its entirety to
read as follows:

         "2.1. Buyer will purchase up to $4,500,000 of combined Inventory and
         Factored Inventory from Company, on a revolving basis, upon the terms
         and conditions set forth herein, provided that, Buyer shall not be
         obligated to purchase more than $2,600,000 of Inventory, on a revolving
         basis, pursuant to Section 2.2 below, and provided further that Company
         will repurchase, as necessary, Inventory or Factored Inventory such
         that the combined amount of Inventory and Factored Inventory will not
         exceed $4,000,000 subsequent to November 14, 2006."

2.   General

     2.1 On and after the effective date of this Third Amendment, each reference
in the Restated Agreement to "the Agreement," "this Agreement," "hereunder" and
"hereof" or words of like import shall refer to the Restated Agreement, as
amended by this Third Amendment. The Restated Agreement, as amended by this
Third Amendment, is and shall continue to be in full force and effect and is
hereby in all respects ratified and confirmed.

     2.2. This Third Amendment shall be governed by and construed in accordance
with the substantive laws of the United States and the State of California,
without regard to or application of California's conflicts of law rules. Any
litigation arising out of or relating to this Third Amendment shall take place
exclusively in the appropriate state or federal court having jurisdiction in
Santa Clara County, California, and each party hereby irrevocably consents to
the jurisdiction of such courts.

     2.3. The Restated Agreement, as amended by this Third Amendment, represents
the entire agreement between the parties hereto concerning the subject matter
hereof and supersedes any and all prior or contemporaneous correspondence,
quotations and negotiations. The Restated Agreement, as amended by this Third
Amendment, supersedes and will take precedence over any conflicting terms in any
purchase order invoice, confirmation or other similar document.

<PAGE>

     2.4 This Third Amendment may be executed in two or more counterparts, each
of which shall be deemed an original, but all of which together shall constitute
one and the same instrument. This Third Amendment may be executed and delivered
by telecopy or facsimile and execution in such manner shall constitute an
original.

IN WITNESS WHEREOF, the parties hereto, intending to be legally bound, have
executed this Third Amendment as of the date first written above.

            COMPANY:

            Intraop Medical Corporation

            By: /s/ Howard Solovei
            ----------------------
            Name: Howard Solovei
            Title: Chief Financial Officer

            BUYER:

            E.U. Capital Venture, Inc

            By: /s/ Yvonne Morkner
            ----------------------
            Yvonne Morkner
            Secretary/Treasurer

            BUYER

            E.U.C. Holding

            By: /s/ Mogens Simonsen by Yvonne Morkner as attorney in fact
            -------------------------------------------------------------
            Mogens Simonsen by Yvonne Morker as attorney in fact
            PresidentExhibit 4.1

                         AFFINITY TECHNOLOGY GROUP, INC.
                    8807-A Two Notch Road, Columbia, SC 29223

September 12, 2006

Investor
Address
City, State Zip Code

Dear Investor,

This letter is being delivered in connection with the consummation of the
transaction contemplated by that certain Amended and Restated Convertible Note
Purchase Agreement (the "Purchase Agreement") among Affinity Technology Group,
Inc. ("Affinity") and the addressee of this letter, among others. Capitalized
terms that are not defined herein shall have the meanings ascribed to such terms
in the Purchase Agreement.

As additional consideration for you to enter into the Purchase Agreement,
Affinity hereby agrees and covenants as follows:

Affinity shall: (i) on or before January 31, 2007 prepare and file with the
Securities and Exchange Commission (the "Commission") a registration statement
with respect to the Common Stock issuable upon conversion of the Notes (the
"Registrable Securities"); (ii) use its best efforts to cause such registration
statement to become effective; (iii) prepare and file with the Commission such
amendments and supplements to such registration statement and the prospectus
used in connection with such registration statement as may be necessary to
comply with the provisions of the Securities Act and the rules thereunder with
respect to the disposition of all securities covered by such registration
statement; (iv) use its best efforts to maintain the continued effectiveness of
such registration statement for at least one hundred and eighty days from and
after the date of effectiveness; (v) furnish to each holder of Registrable
Securities, without charge, such number of copies of the registration statement,
any pre-effective or post-effective amendment thereto, the prospectus, including
each preliminary prospectus and any amendments or supplements thereto, in each
case in conformity with the requirements of the Securities Act, and such other
related documents as any holder of Registrable Securities may reasonably request
in order to facilitate the disposition of Registrable Securities held by such
holder; (vi) use its best efforts (A) to register and qualify the securities
covered by such registration statement under such other securities or "Blue Sky"
laws of such states where an exemption from registration is not available and as
shall be reasonably requested by any holder and (B) to obtain the lifting of any
suspension of the qualification (or exemption from qualification) of the offer
and sale of any of the Registrable Securities in any state, at the earliest
possible moment.; (vii) promptly notify all holders of Registrable Securities of
any stop order issued or threatened to be issued by the Commission in connection
therewith and take all reasonable actions required to prevent the entry of such
stop order or to remove it if entered; (viii) use its best efforts to cause the
Registrable Securities covered by such registration statement (A) to be
registered for listing or qualification on any national securities exchange or
interdealer quotation system on which the Common Stock of Affinity is then
listed or qualified.

                                                 Affinity Technology Group, Inc.
                                                 By: /s/ Joseph A. Boyle
                                                 Name:  Joseph A. Boyle
                                                 Title: Chief Executive OfficerExhibit 10(f)(8) 
	 
	
NQSO – NED ANNUAL GRANT

NQXXXX- XX

STOCK OPTION AGREEMENT
PURSUANT TO THE
COMTECH TELECOMMUNICATIONS CORP.
2000 STOCK INCENTIVE PLAN

Dear [Director Name]:

Preliminary Statement

                                As a non-employee director of Comtech Telecommunications Corp. (the “Company”), you were
automatically granted on [Date] (the “Grant Date”), pursuant to the terms of The Comtech
Telecommunications Corp. 2000 Stock Incentive Plan (the “Plan”), a non-qualified stock
option (the “Option”) to purchase the number of shares of the Company’s common stock,
$.10 par value per share (the “Common Stock”), set forth below.

The terms of the grant are as follows:

                                1.         Tax Matters. The Option granted hereby is a non-qualified stock option. No part of the Option granted hereby is
intended to qualify as an “incentive stock option” under Section 422 of the Internal Revenue
Code of 1986, as amended (the “Code”).

                                2.         Grant of Option. Subject in all respects to the Plan and the terms and conditions set forth herein and therein, you
are hereby granted an Option to purchase from the Company [# of options] shares of Common Stock at
a price per share of $[Price] (the “Option Price”).

                                3.         Exercise. The Option shall become exercisable in installments over a three (3) year period, commencing on the
Grant Date, at the rate of 25% effective on the first and second anniversaries of the Grant Date
and 50% on the third anniversary of the Grant Date (each, a “Vesting Date”), which shall
be cumulative; provided that you have not incurred a Termination of Directorship prior to the applicable
Vesting Date. To the extent that the Option has become vested and exercisable with respect to a percentage
of shares of Common Stock granted as provided above, the Option may thereafter be exercised by you,
in whole or in part, at any time or from time to time prior to the expiration of the Option as provided
herein and in accordance with Section 13.4(d) of the Plan, to the extent permitted by law, including,
without limitation, the filing of such written form of exercise notice, if any, as may be required
by the Committee and payment in full of the Option Price multiplied by the number of shares of Common
Stock so exercised. Upon expiration of the Option, the Option shall be canceled and no longer exercisable.

                                There shall be no proportionate or partial vesting in the periods prior to each Vesting Date and all
vesting shall occur only on the appropriate Vesting Date.

                                To the extent this Option is not vested upon your Termination of Directorship, the Option shall, upon
such Termination of Directorship, be non-exercisable and shall be canceled. Notwithstanding the foregoing,
upon the occurrence of your death or a Change in Control (as defined in the Plan) prior to your Termination
of Directorship, the Option shall immediately become exercisable with respect to all Common Stock
subject thereto, regardless of whether the Option has vested with respect to such Common Stock.

	

 

	
                                4.         Option Term. Unless terminated earlier as provided below or otherwise pursuant to the terms of the Plan, the Option
shall expire five (5) years after the Grant Date.

                                5.         Termination. Subject to Section 4 above and the terms of the Plan, the Option, to the extent vested at the time
of your Termination of Directorship, shall remain exercisable as follows:

                                (a)        In the event of your Termination of Directorship by reason of your death, disability, resignation,
failure to stand for reelection or failure to be reelected or otherwise, the Option, to the extent
exercisable and not exercised, shall remain exercisable to the extent exercisable on the date of
your Termination of Directorship (or in the case of death, by your estate or by the person given
authority to exercise such Options by your will or by operation of law) at any time prior to the
expiration of the stated term of such Option.

                                (b)        Except as provided in (a) above, in the event of your Termination of Directorship for any reason or
no reason whatsoever, no Option that was not exercisable as of the date of Termination of Directorship
shall thereafter become exercisable upon Termination of Directorship and such Option shall terminate
and become null and void upon such Termination of Directorship. 

                                (c)        In the event your Termination of Directorship is for Cause, all Options held by you shall thereupon
terminate and expire as of the date of termination.

                                6.        Restriction on Transfer of Option. The Option granted hereby is not transferable other than by will or by the laws of descent and distribution
and during your lifetime may be exercised only by you. In addition, the Option shall not be assigned,
negotiated, pledged or hypothecated in any way (whether by operation of law or otherwise), and the
Option shall not be subject to execution, attachment or similar process. Upon any attempt to transfer,
assign, negotiate, pledge or hypothecate the Option or in the event of any levy upon the Option by
reason of any execution, attachment or similar process contrary to the provisions hereof, the Option
shall immediately become null and void.

                                7.        Rights as a Stockholder. You shall have no rights as a stockholder with respect to any shares covered by the Option unless
and until you have become the holder of record of the shares.

                                8.       Provisions of Plan Control. This grant is subject to all the terms, conditions and provisions of the Plan, including, without
limitation, the amendment provisions thereof, and to such rules, regulations and interpretations
relating to the Plan as may be adopted by the Board of Directors of the Company and as may be in
effect from time to time. Any capitalized term used but not defined herein shall have the meaning
ascribed to such term in the Plan. The Plan is incorporated herein by reference. If and to the extent
that this grant conflicts or is inconsistent with the terms, conditions and provisions of the
Plan, the Plan shall control, and this grant shall be deemed to be modified accordingly.

                                9.         Notices. Any notice or communication given hereunder shall be in writing and shall be deemed to have been
duly given when delivered in person, or by United States mail, to the appropriate party at the address
set forth below (or such other address as the party shall from time to time specify):

	

2

	
                                If to the Company, to:

	 

	 	Comtech Telecommunications Corp.
68 South Service Road, Suite 230
Melville, NY 11747
Attention: Secretary

	 
	
                                If to you, to the address indicated after your signature at the end of this Agreement.

                                10.      Right to Terminate Directorship. Neither the Plan nor the grant or exercise of any Option hereunder shall impose any obligations on
the Company and/or the stockholders of the Company to retain you as a director, nor shall it impose
any obligation on your part to remain as a director of the Company.

                                IN WITNESS WHEREOF, the parties have executed this Agreement on the date and year first above written.

	 

	 	 	COMTECH TELECOMMUNICATIONS CORP.
	[Director’s Signature]	 	 
	Social Security No.	 	 	 
	 	 	 	By:  ___________________________________
	Home Address:	 	 	         Authorized Officer
	 	Street	 	 
	 	 	 	 
	 	City           State          Zip Code	 	 

	

3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00110-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00110-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00110-of-00352.parquet"}]]